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Objectives. The present study sought o investigate whether the 
work of breathing was reduced after heart transplantation. Ac- 
cordingly, the tension time index of the diaphragm was measured 
in patients with heart failure and in transplant recipients. 
Background. Patients with heart failure are frequently limited 
by exertional dyspnea that may be due to the increased work of 
breathing. After heart transplantation, exertional dyspnea is 
markedly diminished. Whether work of breathing is reduced in 
posttransplant recipients is unknown. 
Methods. Nine patients with heart failure, six normal subjects 
and six heart transplant recipients were studied. Transdiaphrag- 
matic pressure was measured throughout exercise. Accessory 
respiratory muscle oxygenation was assessed using near-infrared 
spectroscopy. Peak oxygen consumption, time in inspiration, time 
per breath and maximal inspiratory and expiratory pressures 
were measured in all subjects. 
Results. The tension time index remained markedly abnormal 
after heart transplantation both at rest ([mean _+ SD] normal 
group 0.01 -+ 0.006, heart failure group 0.026 -+ 0.018, trans- 
plant group 0.058 -+ 0.015, p < 0.004) and at peak exercise 
(normal group 0.03 -+ 0.02, heart failure group 0.10 -+ 0.03, 
transplant group 0.10 -+ 0.04, p < 0.0001). Accessory respiratory 
muscle deoxygenation was present only in patients with heart 
failure (near-infrared absorbency changes [arbitrary units]: nor- 
mal group -3 -+ 6, heart failure group 28 -+ 5, transplant group 
-3.5 -+ 4.4, p < 0.0001). 
Conclusions. Although eart transplantation alleviates dyspnea 
in patients with heart failure, the work of breathing as assessed by 
the tension time index of the diaphragm is not decreased. Ame- 
lioration of exertional dyspnea is achieved by other mechanisms, 
such as improved respiratory muscle perfusion. 
(J Am Coll Cardio11996;28:391-5) 
Patients with heart failure are frequently imited by exertional 
dyspnea. During exercise, these patients exhibit an excessive 
ventilatory esponse that may result from excessive dead space 
ventilation, increased lactic acidosis or decreased perfusion 
(1,2). After heart transplantation, exertional dyspnea is dra- 
matically improved. Whether this alleviation of exertional 
dyspnea is related to improved lung compliance, increased 
perfusion of respiratory or leg musculature, or both, or greater 
respiratory muscle strength isunclear. To investigate which of 
these mechanisms underlies the subjective improvement in
dyspnea fter transplantation, the work of breathing estimated 
from the tension time index of the diaphragm (3), accessory 
respiratory muscle oxygenation and respiratory muscle 
strength were measured in transplant recipients, patients with 
heart failure and normal subjects at rest and during exercise. It
was hypothesized that diminished work of breathing after 
transplantation would be a major contributor to the improve- 
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ment in exertional dyspnea. Surprisingly, work of breathing 
and respiratory strength were not significantly different after 
transplantation. However, regional perfusion of respiratory 
musculature was normalized, suggesting that amelioration of
this symptom is related to improved perfusion. 
Methods  
Patients. Nine patients with chronic congestive heart fail- 
ure (eight men and one woman, mean [_+SD] age 62 _+ 10 
years) were studied. The cause of heart failure was coronary 
artery disease in six patients and dilated cardiomyopathy in 
three. Five patients had New York Heart Association func- 
tional class III congestive heart failure, two class II and two 
class I. Left ventricular ejection fraction averaged 18 _+ 7%. 
All patients were receiving digoxin, diuretic agents and 
angiotensin-converting e zyme inhibitors. 
Six heart ransplant recipients also participated in the study 
(mean age 62 _+ 7 years, mean ejection fraction 58 _+ 11%, 
peak oxygen consumption 21 _+ 2.7 ml/kg per rain). All 
transplant recipients were male and were studied amean of 2.7 
years after transplantation. All patients were receiving cyclo- 
sporine A, prednisone and azathioprine. No patient had a 
rejection episode within 1 month before the exercise test. Rest 
hemodynamic measurements performed at the same time as a 
routine surveillance ndomyocardial biopsy within 1 month of 
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exercise revealed a mean pulmonary artery pressure of 16 +_ 
5 mm Hg, pulmonary capillary wedge pressure of 9 _+ 
2 mm Hg, cardiac output of 5.7 _+ 1.2 liters/rain and pulmonary 
vascular esistance of 1.5 +__ 0.7 Wood units. 
Six normal male subjects (mean age 50 + 7 years) also 
participated in the study. No subject had a significant past 
medical history. All patients and normal subjects were cur- 
rently nonsmokers with normal pulmonary function tests. 
The protocol was approved by the Human Studies Subcom- 
mittee at the Philadelphia Veterans Administration Medical 
Center and the Committee on Studies Involving Human 
Beings at the Hospital of the University of Pennsylvania. 
Written informed consent was obtained from all subjects. 
Exercise protocol. On arrival at the exercise laboratory, 
maximal inspiratory and expiratory pressures were measured 
three times at residual volume and total lung capacity, respec- 
tively. Near-infrared fiberoptic light guides were placed on the 
sixth intercostal space at the anterior axillary line over the 
serratus anterior muscle, an accessory inspiratory muscle. 
Esophageal and gastric balloons were inserted after the nares 
were anesthetized with 1% vicous lidocaine. The subjects were 
then positioned upright on a Monarch exercise bicycle rgome- 
ter. A three-way Hans Rudolph valve was used for respiratory 
gas analysis. Arterial saturation was monitored using an Ohm- 
eda ear oximeter. 
After a 3-rain rest period, all subjects performed a bicycle 
exercise test. Exercise was begun at a work load of 0 W and 
increased by 25-W increments every 3 min to the symptom- 
limited maximum. Blood pressure was measured by a cuff 
sphygmomanometer at the end of each work load. Respiratory 
gases, arterial saturation, heart rate, transdiaphragmatic pres- 
sure and near-infrared spectra were monitored throughout 
exercise. Borg scale ratings of perceived yspnea nd fatigue 
were obtained at each work load. 
Near-infrared spectroscopy. Near-infrared spectroscopy 
noninvasively assesses keletal muscle oxygenation (2,4-6). 
Both oxygenated and deoxygenated hemoglobin absorbs light 
at 850 nm, whereas primarily deoxygenated hemoglobin ab- 
sorbs light at 760 nm. Therefore, by monitoring the difference 
in absorption oted at these two wavelengths, it is possible to 
assess changes in hemoglobin oxygenation. The difference in 
absorption at 760 to 850 nm was used to assess serratus 
anterior muscle oxygenation. All studies were performed using 
the same gain settings on the spectrometer. Absorption 
changes were then expressed as arbitrary units of deviation 
from a stable baseline value. The higher the arbitrary unit, the 
greater the muscle deoxygenation. A negative value represents 
an increase in oxygenation. 
Transdiaphragmatic pressures. Measurement of esopha- 
geal, gastric and transdiaphragmatic pressures was performed 
at rest and during exercise. Esophageal and gastric pressures 
were directly measured by 100- to ll0-cm catheters custom 
fitted with 10-cm latex balloons according to the method of 
Milic-Emili et al. (7). Transdiaphragmatic pressure was de- 
rived by electrical subtraction of esophageal pressure from 
gastric pressure. 
During bicycle exercise, the subjects breathed through a 
mouth piece connected to a specially modified two-way non- 
rebreathing valve (Hans Rudolph). The subject inspired air 
through an inspiratory pneumotachygraph (model 3800, Hans 
Rudolph) connected to a variable-reluctance pressure trans- 
ducer (model MP45-871, Validyne Engineering). Expired gas 
was directed through the respiratory valve into the expiratory 
pneumotachygraph (model 3800, Hans Rudolph) and then into 
a 6:1 mixing chamber. Ventilatory frequency, total ventilatory 
cycle duration and inspiratory time per cycle were derived from 
these signals. The time tension index of the diaphragm as 
defined by Bellemare and Grassino (3) was derived for each 
breath as the product of the inspiratory duty cycle and the 
mean transdiaphragmatic pressure divided by the maximal 
voluntary transdiaphragmatic pressure. 
Statistical analysis. Data from patients with heart failure, 
transplant recipients and normal subjects at rest and during 
exercise were compared with Student nonpaired and paired t 
tests or two-way repeated-measures analysis of variance, as 
appropriate. The relations between variables were examined 
by linear regression analysis. A value of p < 0.05 was consid- 
ered significant. Data are expressed as mean value +_ SD. 
Results 
Exercise measurements. Rest heart rate, mean arterial 
blood pressure, oxygen consumption, respiratory quotients and 
arterial saturation were comparable in patients with heart 
failure, transplant recipients and normal subjects (all p = NS) 
(Table 1). At peak exercise, heart rate, mean arterial blood 
pressure and oxygen consumption were significantly reduced 
both in patients with heart failure and in transplant recipients 
compared with that in normal subjects. The respiratory quo- 
tient at peak exercise was similar in all three groups. Arterial 
desaturation was not observed in any of the groups. 
Near-infrared spectroscopy. At all exercise work loads, 760 
to 850 nm absorption was significantly greater in patients with 
heart failure than in normal subjects or transplant recipients. 
Only patients with heart failure demonstrated accessory respi- 
ratory muscle deoxygenation (peak exercise [arbitrary units]: 
normal group -3  +- 6, heart failure group 28 _+ 5, transplant 
group -3.5 +- 4.4, p < 0.001) (Fig. 1). No significant change 
occurred in the 850-nm signal throughout exercise in any of the 
groups, indicating that total blood volume was unchanged 
during exercise. 
Transdiaphragmatic pressure measurements. Rest maxi- 
mal inspiratory mouth pressures tended to be lower in trans- 
plant recipients than in patients with heart failure and normal 
subjects but did not reach statistical significance (normal group 
117 +__ 9.2 mm Hg, heart failure group 104 +__ 15 mm Hg, 
transplant group 81 _+ 14 mm Hg, p = NS). Similar results 
were observed for maximal expiratory mouth pressures (nor- 
mal group 228 + 8 mm Hg, heart failure group 201 + 
31 mm Hg, transplant group 178 ~ 21 mm Hg, p = NS). 
The inspiratory duty cycle (time in inspiration divided by 
time/breath) was comparable between all three groups. The 
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Table 1. Rest and Peak Exercise Measurements 
Normal Subjects Patients With Heart Failure Transplant Recipients 
Rest Exercise Rest Exercise Rest Exercise 
Heart rate (beats/min) 82 ± 11 167 ± 11 85 ± 15 136 ± 18" 89 ± 21 138 -+ 20* 
Mean arterial BP (mm Hg) 96 _+ 6 140 + 9 90 ± 10 114 t 18' 107 ± 8 116 -+ 13" 
Vo 2 (ml/kg per min) 4.2 + 0.8 33 _+ 11 3.4 + 1.3 15.6 _~ 5.9* 4.3 ± 0.6 21 -+ 2.2*¢ 
VE (liters/rain) 11 ± 3 89 + 3 12 ± 3 49 ± 16" 15.0 + 1 53 ± 8* 
Respiratory rate (beats/min) 15 ± 4 32 + 9 18 + 5 39 ± 9 14 + 2 30 ± 6 
RQ 0.78 ± 0.05 1.09 ± 0.15 0.77 ± 0.08 1.03 ± 0.15 0.9 ± (I.03 1.07 -+ 0.08 
NIR (arbitra~ units) -3  ± 6 28 ± 5* 3.5 ± 4.4? 
Arterial saturation (%) 97 ± 1 97 _+ 1 97 -+ 1 96 + 1 97 ± 1 96 + l 
*p < 0.05 versus normal subjects. ?p < 0.05 versus patients with congestive heart failure. Data presented are mean value ± SD. BP = blood pressure; NIR = the 
difference in 760- to 850-nm absorption; RQ = respiratory quotient; VE = expired volume; Vo 2 oxy, gen consumption. 
tension time index (transdiaphragmatic pressure times time in 
inspiration divided by total time/breath) was increased at rest 
and throughout exercise in patients with heart failure and 
transplant recipients compared with that in normal subjects 
(Fig. 2). At maximal exercise, the tension time index was 
0.10 _+ 0.03 for patients with heart failure, 0.10 _+ 0.04 for 
transplant recipients and 0.03 _ 0.02 for normal subjects (p < 
0.001). In one patient in whom transdiaphragmatic pressures 
were measured before and after transplantation, a trend 
toward increasing tension time index at rest and during 
exercise was also observed. 
Ratings of perceived yspnea nd fatigue. Dyspnea was the 
primary limiting symptom in two patients with heart failure, no 
transplant recipients and three normal subjects. In patients 
with heart failure, Borg scale ratings of dyspnea were signifi- 
cantly greater than in normal subjects at the same absolute 
work load and tended to be significantly greater than in heart 
transplant recipients. At maximal work load, Borg scale ratings 
of dyspnea were comparable between all groups (Table 2). 
Similar results were observed for Borg scale ratings of per- 
ceived fatigue. 
Discussion 
In the present study the tension time index of the dia- 
phragm was used to approximate he oxygen cost/breath and to 
Figure 1. Near-infrared absorbency hanges at maximal exercise in 
normal subjects, patients with congestive heart failure (CHF) and 
transplant recipients. 
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provide a measure of the work of breathing in normal subjects 
and in patients with heart failure and transplant recipients (3). 
The study demonstrates that in heart ransplant recipients, the 
work of breathing as assessed from the tension time index of 
the diaphragm isnot decreased. Respiratory. muscle strength is 
unchanged. However, regional perfusion of accessory respira- 
tory muscles improves ignificantly and is comparable to the 
normal response. 
Chronic venous pulmonary hypertension i patients with 
heart failure leads to fibrotic changes in the lung parenchyma 
and blood vessels and results in decreased lung compliance and 
bronchoconstriction (8,9). These changes increase the energy 
costs of respiration. Indeed, at rest and during exercise, 
patients with heart failure exhibit an increased tension time 
index (10) and increased work of breathing (11). In our group 
of transplant recipients, the tension time index of the dia- 
phragm remained elevated at rest and throughout exercise 
compared with that in normal subjects but was similar to that 
in patients with heart failure. Persistent pulmonary hyperten- 
sion is an unlikely explanation for the increased work of 
breathing after heart transplantation because pulmonary ve- 
nous hypertension reverses by 1 month (12). All our patients 
were studied at least 6 months after transplantation, and all 
had normal rest hemodynamic measurements within the pre- 
Figure 2. Plot of tension time index at rest and during exercise in 
normal subjects, patients with congestive heart failure (CHF) and 
transplant recipients. 
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Table 2. Borg Scale Ratings of Perceived Dyspnea nd Fatigue 
Dyspnea Fatigue 
Normal Patients With Transplant Normal Patients With Transplant 
Work Load (W) Subjects Heart Failure Recipients Subjects Heart Failure Recipients 
0 9.3 ± 1.8 7,5 -+ 1.2 7.8 ± 1.8 
25 6.7 ± 0.8 10.3 ± 2.4* 8,8 ± 2* 6.8 _+ 1.1 10.3 ± 2.4* 9.2 ± 2.8* 
50 7.3 ± 1.5 13.5 ± 3.0* 9,7 ± 2.5'1 7.5 ± 1.6 13.3 ± 3* 11 -2-_ 2.8* 
75 9.2 ± 1.7 15.1 ± 2.9* 13.3 ± 2.3* 9 ± 1.8 14.1 ± 2.5* 14.8 + 2.7* 
Maximum 16.7 _+ 2 16.6 ± 1.4 15.3 ± 1.5 18 ± 1 17.8 ± 1.4 18.3 ± 1.5 
*p < 0.05 versus normal subjects, tp < 0.05 versus patients with heart failure. Data presented are mean value ± SD. 
ceding month. Thus, at least at rest, the elevated tension time 
index was not related to persistent pulmonary hypertension. 
Although exercise hemodynamic measurements were not re- 
corded in the present study, previous tudies in heart trans- 
plant recipients have shown elevated pulmonary pressures 
during exercise (13,14). Therefore, we cannot exclude that 
exercise-induced pulmonary hypertension did not contribute to 
elevated tension time index during exercise. However, it is 
more likely that irreversible structural changes occur in the 
lung that increase respiratory work through adecrease in lung 
compliance. Analysis of lung biopsies in adolescents with 
mitral stenosis after successful surgical therapy has demon- 
strated irreversible lung changes (15). No longitudinal studies 
have been performed inpatients with heart failure to assess the 
reversibility of lung parenchymal changes. Persistent fibrotic 
changes resulting in an increased work of breathing would not 
preclude some improvement in lung compliance. Previously, 
Hosenpud et al. (16) compared spirometric results before and 
after transplantation a d noted improvements in lung volumes 
and flow rates. This posttransplantation improvement was 
attributed to a combination ofreduced cardiac size, interstitial 
edema and pleural effusions. Thus, in transplant recipients 
with the same mean transdiaphragmatic pressure, the change 
in volume should be greater. Improved static and dynamic lung 
compliance probably contributes to an alleviation of dyspnea 
in transplant recipients despite no alteration in the absolute 
work of the diaphragm. 
Respiratory muscle strength assessed from maximal inspira- 
tory and expiratory mouth pressures tended to be lower in 
transplant recipients than in patients with heart failure or 
normal subjects but did not achieve statistical significance. 
Maintenance therapy with corticosteroids in our transplant 
recipients may have contributed to this trend. Skeletal muscle 
metabolic, enzymatic and histochemical bnormalities have 
been described in patients with heart failure (1%21). Dimin- 
ished skeletal muscle endurance (22) and generalized muscle 
atrophy (23) have also been described in patients with heart 
failure. To what extent these intrinsic muscle changes are 
reversible is unclear, although presumably those changes re- 
lated to deconditioning are at least partially reversible. 
Few studies have focused on skeletal muscle function after 
transplantation. Muscle biopsies from renal transplant recipi- 
ents receiving maintenance orticosteroids have demonstrated 
reduced myofibrillar volume and a decreased capillary/fiber 
ratio (24,25). Braith et al. (26) recently described a reduction 
in skeletal muscle strength in heart ransplant recipients up to 
18 months after transplantation. Metabolic abnormalities dur- 
ing exercise have been reported in patients up to 1 year after 
transplantation (27). Bussieres-Chafe etal. (28,29) described 
an increase in mitochrondrial enzyme activity and fiber size 
from serial percutaneous calf biopsies in 13 patients 1 year 
after transplantation. Decreased respiratory muscle ndurance 
in transplant recipients has also been described (30,31). Thus, 
both muscle endurance and strength tend to be reduced in 
transplant recipients. 
Accessory respiratory muscle deoxygenation has been de- 
scribed uring exercise in patients with heart failure (2) and in 
those with mitral stenosis (32) using near-infrared spectros- 
copy, a noninvasive technique that provides qualitative mea- 
surement of deoxygenated skeletal muscle hemoglobin by 
measuring the difference inabsorbency of760- to 850-nm light. 
Using this technique, we again observed progressive respira- 
tory muscle deoxygenation during exercise in patients with 
heart failure but not in normal subjects or transplant recipi- 
ents. These findings suggest that improved regional perfusion 
of the respiratory muscles occurs after heart transplantation. 
This improved muscle perfusion may be the primary mecha- 
nism by which dyspnea is relieved. 
After heart transplantation, the symptom of dyspnea is 
greatly decreased in patients with heart failure. However, 
quantification of dyspnea using a unidimensional scale during 
bicycle exercise demonstrated only small differences in per- 
ceived dyspnea between patients with heart failure and trans- 
plant recipients and only at submaximal work loads. Ratings of 
perceived yspnea remained higher in transplant recipients 
than in normal subjects. Use of alternate scales that incorpo- 
rate a more multidimensional measure of dyspnea may have 
yielded ifferent results. The dyspnea index, which normalizes 
minute ventilation by maximal capacity, would probably have 
been reduced in transplant recipients because we have previ- 
ously shown (31) that maximal voluntary ventilation and 
maximal sustainable ventilatory capacity are improved in trans- 
plant recipients. Thus, although the absolute amount of work 
may be the same, transplant recipients have the capacity to do 
greater amounts of work. 
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Study limitations. The present study is limited by its cross- 
sectional nature and the small sample size. However, the 
findings in this small homogeneous group were extremely 
consistent. Moreover, the one patient with longitudinal data 
demonstrated a slightly increased tension time index after 
transplantation. 
Exercise hemodynamic measurements were not obtained. 
However, several previous studies have adequately described 
the hemodynamic response to exercise in these patient groups 
(13,14). Transplant recipients will demonstrate an improved 
hemodynamic response with lower pulmonary pressures and a 
higher cardiac output that is intermediate between normal 
subjects and patients with heart failure. Lung compliance 
measurements were also not recorded. Although this informa- 
tion would have aided our understanding of the findings, the 
observation that work of the diaphragm remains elevated after 
transplantation is important. Other possible etiologies for 
improvement in dyspnea after transplantation, such as stimu- 
lation of airway and lung parenchymal receptors, were not 
investigated. Further studies will be needed to further clarify 
the mechanisms underlying the relief of dyspnea in patients 
with heart failure after transplantation. 
Clinical implications. The present study implies that pul- 
monary work of breathing is not the major determinant of 
dyspnea in patients with heart failure. Other mechanisms, such 
as decreased lung compliance or decreased muscle perfusion, 
may represent the primary stimuli for dyspnea in these pa- 
tients. Additional studies are warranted to identify the primary 
stimulus for dyspnea in patients with heart failure. 
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